A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC

Condition:   HER2-positive Breast Cancer Intervention:   Drug: Eribulin mesylate injection、Pertuzumab、Trastuzumab Sponsor:   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials